John, thank you. As John mentioned, Flotek filed its quarterly report on Form 10-Q for the quarter ended June 30, 2014, with the U.S. Securities and Exchange Commission yesterday afternoon. Flotek reported that revenue for the quarter ended June 30, 2014, was $105.3 million compared to $93.6 million for the quarter ended June 30, 2013. Consolidated revenue for the 3 months ended June 30, 2014, increased $11.7 million or 12.5% relative to the comparable period of 2013. This increase in revenue was primarily due to increased sales of stimulation chemical additives in our Energy Chemical Technologies segment. As expected, seasonal activity declines in Canada impacted revenue by nearly $3 million collectively in April and May. In addition, the transition to an optimized CnF blend in a key basin caused a transient reduction in revenue of approximately $1 million, as well as a modest short-term impact on energy chemistry gross margins. For the quarter ended June 30, 2014, the company reported net income of $11.0 million or $0.20 per share on a fully diluted basis compared to net income of $8.4 million, or $0.16 per share on a fully diluted basis for the quarter ended June 30, 2013. Earnings before interest, taxes, depreciation and amortization or EBITDA for the quarter ended June 30, 2014, was $22.0 million compared to $17.6 million for the quarter ended June 30, 2013. Stock compensation expense for the quarter ended June 30, 2014, totaled $2.4 million compared to $3.6 million for the quarter ended June 30, 2013. Selling, general and administrative expenses remained relatively flat for the 3 months ended June 30, 2014, as compared to the same period of 2013. SG&A costs as a percentage of revenue declined from 22.5% for the second quarter of 2013 to 19.8% for the current quarter as revenue grew faster than SG&A costs. The company recorded an income tax provision of $6.0 million, reflecting an effective tax rate of 35.1% for the 3 months ended June 30, 2014, compared to an income tax provision of $4.7 million, reflecting an effective tax rate of 35.9% for the comparable period in 2013. Flotek continues to sport one of the strongest balance sheets in the industry. The current ratio continues to improve. During the quarter, Flotek's total outstanding debt did increase by $1.9 million, or 3.5% since March 31, 2014, largely a result of seasonal inventory accumulation and higher estimated tax payments. However, during the 6 months ended June 30, 2014, Flotek has reduced outstanding debt by $5.2 million, or 8.4% from the balance at December 31, 2013. Accounts receivable at June 30, 2014, were $65.9 million compared to $65.0 million as of December 31, 2013. The company's allowance for doubtful accounts was 1.2% at June 30, 2014. Inventories in the quarter rose by $10.2 million, primarily as a result of traditional seasonal increase in citrus product inventory held at Florida Chemical. Now I would like to turn the call over to Steve Reeves, who will discuss second quarter operating highlights. Steve?